$VKTX: Consolidation in Viking Therapeutics Provides an Opportunity

Viking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare disease programs include novel selective thyroid receptor-β agonist approach. These and other programs are currently within phases 1, 2 and preclinical. Viking Therapeutics saw IPO back in 2015. Since then, investors can trade it under the … <a href="https://www.forexcycle.com/daily-forex-reports/137084-vktx-consolidation-in-viking-therapeutics-provides-an-opportunity.html">Continue reading<span> "$VKTX: Consolidation in Viking Therapeutics Provides an Opportunity"</span></a>